TY - JOUR
T1 - Nebulized medications in the emergency department
T2 - A narrative review of nontraditional agents
AU - Weant, Kyle A.
AU - Baum, Regan A.
AU - Hile, Garrett B.
AU - Humphries, Roger L.
AU - Metts, Elise L.
AU - Miller, Amy R.
AU - Woolum, Jordan A.
AU - Bailey, Abby M.
N1 - Publisher Copyright:
© American Society of Health-System Pharmacists 2023.
PY - 2024/2/15
Y1 - 2024/2/15
N2 - Purpose: This article summarizes emerging nontraditional therapies administered via the nebulization route for use in the emergency department (ED). Summary: Although traditional routes of medication administration (eg, intravenous) have been the mainstay of administration modalities for decades, these routes may not be appropriate for all patients. Nowhere is this more readily apparent than in the ED setting, where patients with a variety of presentations receive care. One unique route for medication administration that has increasingly gained popularity in the ED is that of aerosolized drug delivery. This route holds promise as direct delivery of medications to the site of action could yield a more rapid and effective therapeutic response while also minimizing systemic adverse effects by utilizing a fraction of the systemic dose. Medication administration via nebulization also provides an alternative that is conducive to rapid, less invasive access, which is advantageous in the emergent setting of the ED. This review is intended to analyze the existing literature regarding this route of administration, including the nuances that can impact drug efficacy, as well as the available literature regarding novel, noncommercial nebulized medication therapy given in the ED. Conclusion: Multiple medications have been investigated for administration via this route, and when implementing any of these therapies several practical considerations must be taken into account, from medication preparation to administration, to ensure optimal efficacy while minimizing adverse effects. The pharmacist is an essential bedside team member in these scenarios to assist with navigating unique and complex nuances of this therapy as they develop.
AB - Purpose: This article summarizes emerging nontraditional therapies administered via the nebulization route for use in the emergency department (ED). Summary: Although traditional routes of medication administration (eg, intravenous) have been the mainstay of administration modalities for decades, these routes may not be appropriate for all patients. Nowhere is this more readily apparent than in the ED setting, where patients with a variety of presentations receive care. One unique route for medication administration that has increasingly gained popularity in the ED is that of aerosolized drug delivery. This route holds promise as direct delivery of medications to the site of action could yield a more rapid and effective therapeutic response while also minimizing systemic adverse effects by utilizing a fraction of the systemic dose. Medication administration via nebulization also provides an alternative that is conducive to rapid, less invasive access, which is advantageous in the emergent setting of the ED. This review is intended to analyze the existing literature regarding this route of administration, including the nuances that can impact drug efficacy, as well as the available literature regarding novel, noncommercial nebulized medication therapy given in the ED. Conclusion: Multiple medications have been investigated for administration via this route, and when implementing any of these therapies several practical considerations must be taken into account, from medication preparation to administration, to ensure optimal efficacy while minimizing adverse effects. The pharmacist is an essential bedside team member in these scenarios to assist with navigating unique and complex nuances of this therapy as they develop.
KW - administration
KW - emergency service
KW - inhalation
KW - pharmacists
UR - https://www.scopus.com/pages/publications/85184834791
UR - https://www.scopus.com/inward/citedby.url?scp=85184834791&partnerID=8YFLogxK
U2 - 10.1093/ajhp/zxad273
DO - 10.1093/ajhp/zxad273
M3 - Review article
C2 - 37879862
AN - SCOPUS:85184834791
SN - 1079-2082
VL - 81
SP - 88
EP - 105
JO - American Journal of Health-System Pharmacy
JF - American Journal of Health-System Pharmacy
IS - 4
ER -